tiprankstipranks
Advertisement
Advertisement
Maintained Buy on Tango: Vopimetostat Data and KRAS Combo Strategy Support Unchanged $46 Price Target
PremiumRatingsMaintained Buy on Tango: Vopimetostat Data and KRAS Combo Strategy Support Unchanged $46 Price Target
14d ago
Midday Fly By: Netflix forecast fuels fears, SpaceX tumbles after scrubbing test
Premium
The Fly
Midday Fly By: Netflix forecast fuels fears, SpaceX tumbles after scrubbing test
27d ago
Tango Therapeutics price target raised to $40 from $36 at Mizuho
Premium
The Fly
Tango Therapeutics price target raised to $40 from $36 at Mizuho
27d ago
Video: Semiconductor stocks broadly lower, dragging on Nasdaq
PremiumThe FlyVideo: Semiconductor stocks broadly lower, dragging on Nasdaq
2M ago
Tango Therapeutics upgraded to Buy from Hold at Jefferies
Premium
The Fly
Tango Therapeutics upgraded to Buy from Hold at Jefferies
2M ago
Tango Therapeutics Adds Veteran Biopharma Leader to Board
Premium
Company Announcements
Tango Therapeutics Adds Veteran Biopharma Leader to Board
2M ago
Tango Therapeutics announces $500M common stock offering
PremiumThe FlyTango Therapeutics announces $500M common stock offering
2M ago
Tango Therapeutics price target raised to $69 from $55 at Leerink
Premium
The Fly
Tango Therapeutics price target raised to $69 from $55 at Leerink
2M ago
Catanzaro Raises TNGX Price Target to $36, Reiterates Buy on Promising Vopimetostat/Daraxonrasib Data in Pancreatic Cancer
Premium
Ratings
Catanzaro Raises TNGX Price Target to $36, Reiterates Buy on Promising Vopimetostat/Daraxonrasib Data in Pancreatic Cancer
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100